Status:
COMPLETED
Leucine-enriched Branched-chain Amino Acid on Muscle Thickness, Interleukin-6, SOFA Score in Critical Illness
Lead Sponsor:
Indonesia University
Conditions:
Critical Illness
Muscle Wasting
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
The goal of this clinical trial study is to test effects of leucine-enriched branched-chain amino acid (BCAA) in critically ill patients. The main questions it aims to answer are: • How are the change...
Detailed Description
The goal of this clinical trial study is to test effects of leucine-enriched branched-chain amino acid (BCAA) in critically ill patients. The main questions it aims to answer are: • How are the change...
Eligibility Criteria
Inclusion
- new admission to intensive care unit (ICU) in first 24 hours
- aged 18-65 years
- SOFA score \>= 4
Exclusion
- pregnant
- ultrasound examination cannot be performed under these circumstances: deformities, open wounded, prosthetics on right leg, amputated above right patella
- body mass index \<16 kg/m2
- chronic kidney disease stage 3-5
- diabetes mellitus uncontrolled blood glucose (BG) (BG \>200 mg/dL)
- neuromuscular diseases with musculus quadriceps femoris dextra paralysis
- autoimmune diseases
- referral from another ICU
Key Trial Info
Start Date :
December 14 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 10 2024
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT06167772
Start Date
December 14 2023
End Date
May 10 2024
Last Update
July 23 2024
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Dr. Cipto Mangunkusumo Hospital
Jakarta Pusat, Jakarta Special Capital Region, Indonesia, 10430
2
Universitas Indonesia Hospital
Depok, West Java, Indonesia